Antônio Carlos Marqueti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Antônio Carlos Marqueti has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Rosany Larissa Brito de Oliveira
Federal University of Sergipe
3 shared publications - Álvaro Bezerra Cardoso
Federal University of Sergipe
3 shared publications - Cleverson Luciano Trento
Universidade Federal de Sergipe, Brasil
2 shared publications - Iandra Luah Souza Maia
Federal University of Sergipe
2 shared publications - Alina Lúcia de Oliveira Barros
Universidade Federal de Sergipe
1 shared publication - Ana Luísa Carvalho de Meneses Silva
Universidade Federal De Sergipe. Faculdade de Odontologia
1 shared publication
Latest Publications
- Open Access
- 18 July 2025
- Published by Universidade Estadual de Campinas in Brazilian Journal of Oral Sciences
- Vol. 24, e257209
Oral manifestations in patients undergoing chemotherapy
The proposed treatment for malignant neoplasms can be isolated or combined, involving resective surgery, radiotherapy, chemotherapy, and/or hormone replacement. Chemotherapy induces extensive immunosuppression and affects both healthy and abnormal cells. This cytotoxicity from the treatment has a significant effect that can lead to changes in the oral mucosa. The severity is related to the type of drug, duration of treatment, dosage used, level of oral hygiene during treatment, and the individual’s age. Therefore, monitoring oral health before, during, and after antineoplastic therapy is essential. Aim: To evaluate the main oral manifestations that oncology patients presented before and after 15 days from the first administration of chemotherapy medication. Methods: A prospective observational study was conducted with 31 individuals treated at a Hospital Oncology and Hematology Service. The evaluations included the following steps: (1) Patient identification and completion of assessment forms; (2) Clinical examination of the oral cavity before and after the start of chemotherapy; and (3) Providing guidance to patients regarding oral care during oncological treatment. Results: It was observed that 70.96% of patients exhibited oral manifestations 15 days after the first infusion of antineoplastic drugs. The main changes identified included xerostomia and oral mucositis. Conclusion: Dental follow-up during chemotherapy is essential for preventing and managing potential oral emergencies, thereby avoiding interruptions in systemic treatment and ultimately enhancing the quality of life for these patients.
- 18 July 2025
- Published by Universidade Estadual de Campinas in Brazilian Journal of Oral Sciences
- Vol. 24, e257209
Open AccessOral manifestations in patients undergoing chemotherapy
The proposed treatment for malignant neoplasms can be isolated or combined, involving resective surgery, radiotherapy, chemotherapy, and/or hormone replacement. Chemotherapy induces extensive immunosuppression and affects both healthy and abnormal cells. This cytotoxicity from the treatment has a significant effect that can lead to changes in the oral mucosa. The severity is related to the type of drug, duration of treatment, dosage used, level of oral hygiene during treatment, and the individual’s age. Therefore, monitoring oral health before, during, and after antineoplastic therapy is essential. Aim: To evaluate the main oral manifestations that oncology patients presented before and after 15 days from the first administration of chemotherapy medication. Methods: A prospective observational study was conducted with 31 individuals treated at a Hospital Oncology and Hematology Service. The evaluations included the following steps: (1) Patient identification and completion of assessment forms; (2) Clinical examination of the oral cavity before and after the start of chemotherapy; and (3) Providing guidance to patients regarding oral care during oncological treatment. Results: It was observed that 70.96% of patients exhibited oral manifestations 15 days after the first infusion of antineoplastic drugs. The main changes identified included xerostomia and oral mucositis. Conclusion: Dental follow-up during chemotherapy is essential for preventing and managing potential oral emergencies, thereby avoiding interruptions in systemic treatment and ultimately enhancing the quality of life for these patients.
- Open Access
- 16 July 2025
- Published by Universidade Paranaense in Arquivos de Ciências da Saúde da UNIPAR
- Vol. 29 (2) , 862-874
RECIDIVA EM TECIDO MOLE DE CERATOCISTO ODONTOGÊNICO APÓS TRATAMENTO CIRÚRGICO DE LESÃO INTRAÓSSEA
O ceratocisto odontogênico tem sua origem etiológica a partir de restos celulares da lâmina dentária. Surge mais comumente em região posterior de mandíbula, acometendo ligeiramente mais o sexo masculino na terceira e quarta década de vida. Existem poucos estudos na literatura sobre recidivas em tecido mole de ceratocistos odontogênicos. O presente estudo tem como objetivo relatar um caso de recidiva em tecido mole de um ceratocisto odontogênico intraósseo. Inicialmente, a lesão localizava-se na maxila esquerda, envolvendo o dente incluso 23 com extensão desde o ápice do dente 21 ao 27. Após 2 anos de exérese da lesão primária em centro cirúrgico, sob anestesia geral, observou-se lesão bolhosa de diâmetro aproximado de 1 cm, em gengiva inserida na região vestibular entre as unidades dentárias 22 e 24. Desta vez, o tratamento consistiu na excisão local com curetagem e saucerização com broca cirúrgica do osso adjacente, sob anestesia local. O exame anatomopatológico confirmou tratar-se de ceratocisto odontogênico, contudo, com localização em tecidos moles. O paciente vem sendo acompanhado clínica e radiograficamente há 3 anos após a segunda intervenção cirúrgica sem evidências de recidiva.
- 16 July 2025
- Published by Universidade Paranaense in Arquivos de Ciências da Saúde da UNIPAR
- Vol. 29 (2) , 862-874
Open AccessRECIDIVA EM TECIDO MOLE DE CERATOCISTO ODONTOGÊNICO APÓS TRATAMENTO CIRÚRGICO DE LESÃO INTRAÓSSEA
O ceratocisto odontogênico tem sua origem etiológica a partir de restos celulares da lâmina dentária. Surge mais comumente em região posterior de mandíbula, acometendo ligeiramente mais o sexo masculino na terceira e quarta década de vida. Existem poucos estudos na literatura sobre recidivas em tecido mole de ceratocistos odontogênicos. O presente estudo tem como objetivo relatar um caso de recidiva em tecido mole de um ceratocisto odontogênico intraósseo. Inicialmente, a lesão localizava-se na maxila esquerda, envolvendo o dente incluso 23 com extensão desde o ápice do dente 21 ao 27. Após 2 anos de exérese da lesão primária em centro cirúrgico, sob anestesia geral, observou-se lesão bolhosa de diâmetro aproximado de 1 cm, em gengiva inserida na região vestibular entre as unidades dentárias 22 e 24. Desta vez, o tratamento consistiu na excisão local com curetagem e saucerização com broca cirúrgica do osso adjacente, sob anestesia local. O exame anatomopatológico confirmou tratar-se de ceratocisto odontogênico, contudo, com localização em tecidos moles. O paciente vem sendo acompanhado clínica e radiograficamente há 3 anos após a segunda intervenção cirúrgica sem evidências de recidiva.
- Open Access
- 21 March 2024
- Published by Fundação Universidade de Pernambuco in Revista de Cirurgia e Traumatologia Buco-Maxilo-Facial
- Vol. 23 (4) , 38-41
Manejo conservador de um ameloblastoma unicístico
Objetivo: Ponderar, através de um relato de caso, os benefícios da escolha por um tratamento conservador em casos de ameloblastoma unicístico. Relato de caso: O presente trabalho relata um ameloblastoma unicístico em uma paciente do sexo feminino com 20 anos que procurou atendimento 2 anos após notar a presença da lesão. Foi realizado um protocolo de tratamento conservador, e após 1 anos e 6 meses de proservação constatou-se uma recidiva, que foi removida por enucleação e curetagem. Conclusão: O ameloblastoma não é um tumor maligno com capacidade de metástase e não deve ser tratado como tal. O tratamento radical dessa patologia cria sequelas que tornam a reabilitação difícil. Em contrapartida, o tratamento conservador pode ser realizado em ambiente ambulatorial, trazendo baixos impactos funcionais, estéticos e psicológicos ao paciente.
- 21 March 2024
- Published by Fundação Universidade de Pernambuco in Revista de Cirurgia e Traumatologia Buco-Maxilo-Facial
- Vol. 23 (4) , 38-41
Open AccessManejo conservador de um ameloblastoma unicístico
Objetivo: Ponderar, através de um relato de caso, os benefícios da escolha por um tratamento conservador em casos de ameloblastoma unicístico. Relato de caso: O presente trabalho relata um ameloblastoma unicístico em uma paciente do sexo feminino com 20 anos que procurou atendimento 2 anos após notar a presença da lesão. Foi realizado um protocolo de tratamento conservador, e após 1 anos e 6 meses de proservação constatou-se uma recidiva, que foi removida por enucleação e curetagem. Conclusão: O ameloblastoma não é um tumor maligno com capacidade de metástase e não deve ser tratado como tal. O tratamento radical dessa patologia cria sequelas que tornam a reabilitação difícil. Em contrapartida, o tratamento conservador pode ser realizado em ambiente ambulatorial, trazendo baixos impactos funcionais, estéticos e psicológicos ao paciente.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista de Odontologia da UNESP
- Vol. 53, e20240024
Comparative analysis of microgaps in angled and straight components: a laboratory study
Introduction The dental implant rehabilitation protocol is a well-established treatment option for edentulous patients with a high success rate. However, there are factors that can lead to difficulty in continuation and even complete loss of rehabilitation. Microgaps are spaces found between the implant and prosthetic abutment that are caused by the limit of precision in the manufacturing of the implant. This space can cause micromovements and bacterial microleakage that can compromise the long-term useful life of the implant. Objective Measure and evaluate microgaps in angled and straight implants using scanning electron microscopy. To carry out the study, a total of 30 SIN® osseointegrated implants were used, 15 of which were straight and 15 angled. Material and method For the comparative analysis of these components, scanning electron microscopy was used, carried out by a properly calibrated and experienced researcher. Result It was observed that the microgap measurements of both components are in accordance with the clinically acceptable values presented in the literature, however the microgap values of the angled components were considerably higher compared to the straight components. Conclusion Although the values presented corroborate the data presented in the literature, additional studies are necessary for a more comprehensive and in-depth understanding of the relationship between the microgaps of the morse cone system components.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in Revista de Odontologia da UNESP
- Vol. 53, e20240024
Open AccessComparative analysis of microgaps in angled and straight components: a laboratory study
Introduction The dental implant rehabilitation protocol is a well-established treatment option for edentulous patients with a high success rate. However, there are factors that can lead to difficulty in continuation and even complete loss of rehabilitation. Microgaps are spaces found between the implant and prosthetic abutment that are caused by the limit of precision in the manufacturing of the implant. This space can cause micromovements and bacterial microleakage that can compromise the long-term useful life of the implant. Objective Measure and evaluate microgaps in angled and straight implants using scanning electron microscopy. To carry out the study, a total of 30 SIN® osseointegrated implants were used, 15 of which were straight and 15 angled. Material and method For the comparative analysis of these components, scanning electron microscopy was used, carried out by a properly calibrated and experienced researcher. Result It was observed that the microgap measurements of both components are in accordance with the clinically acceptable values presented in the literature, however the microgap values of the angled components were considerably higher compared to the straight components. Conclusion Although the values presented corroborate the data presented in the literature, additional studies are necessary for a more comprehensive and in-depth understanding of the relationship between the microgaps of the morse cone system components.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 72, e20240018
Pleomorphic adenoma treatment in a patient with neurodegenerative disease: case report
Pleomorphic adenoma (PA) is a benign tumor, responsible for more than 50% of the cases of salivary gland neoplasms, occurring both the major and minor salivary glands. In the oral cavity, the most frequent sites of pleomorphic adenoma are the palate and the lips, with greater preference for females and frequently affecting individuals in the fourth to fifth decade of life. The treatment of choice is based on total lesion excision with a good prognosis, which has a low potential for recurrence and malignant transformation. The objective of the study was reporting a treatment of pleomorphic adenoma localized in the hard palate of the 74-year-old male patient, F.A.S. with Parkinson’s disease. The patient is in outpatient follow-up for over a year with no signs of recurrence. Computed Tomography is an indispensable tool for directing the correct diagnosis, which is only definitive after the histopathological examination. The most indicated treatment with good prognosis is complete surgical excision of the lesion and curettage.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 72, e20240018
Open AccessPleomorphic adenoma treatment in a patient with neurodegenerative disease: case report
Pleomorphic adenoma (PA) is a benign tumor, responsible for more than 50% of the cases of salivary gland neoplasms, occurring both the major and minor salivary glands. In the oral cavity, the most frequent sites of pleomorphic adenoma are the palate and the lips, with greater preference for females and frequently affecting individuals in the fourth to fifth decade of life. The treatment of choice is based on total lesion excision with a good prognosis, which has a low potential for recurrence and malignant transformation. The objective of the study was reporting a treatment of pleomorphic adenoma localized in the hard palate of the 74-year-old male patient, F.A.S. with Parkinson’s disease. The patient is in outpatient follow-up for over a year with no signs of recurrence. Computed Tomography is an indispensable tool for directing the correct diagnosis, which is only definitive after the histopathological examination. The most indicated treatment with good prognosis is complete surgical excision of the lesion and curettage.